<p>以 26.4 倍的市盈率（&#34;P/E&#34;）來看，<strong>ESAB Corporation</strong>（紐約證券交易所代碼：ESAB）目前可能發出看跌信號，因為美國幾乎一半的公司市盈率低於 19 倍，甚至低於 11 倍的市盈率也並不罕見。然而，市盈率可能因某種原因而偏高，需要進一步調查以確定其合理性。</p>
<p>人工智能即將改變醫療保健。這 20 只股票正在從早期診斷到藥物發現等各個方面進行工作。最棒的是——它們的市值都在 100 億美元以下——現在仍然有機會提前佈局。</p>
<p>ESAB 的表現可能更好，因為它的盈利增長低於大多數其他公司。一個可能性是，市盈率偏高是因為投資者認為這種乏力的盈利表現將顯著改善。如果沒有，那麼現有股東可能會對股價的可行性感到非常緊張。</p>
<p>查看我們對 ESAB 的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/708077828-pe-multiple-vs-industry-1-dark-2/1767958651444?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/708077828-pe-multiple-vs-industry-1-dark-2/1767958651444"/></p>
<p>2026 年 1 月 9 日 NYSE:ESAB 市盈率與行業對比</p>
<p>如果你想了解分析師對未來的預測，可以查看我們關於 ESAB 的 <strong>免費</strong> 報告。</p>
<h2>增長是否匹配高市盈率？</h2>
<p>ESAB 的市盈率對於一家預計將實現穩健增長的公司來説是典型的，重要的是，它的表現應該優於市場。</p>
<p>首先回顧一下，我們看到過去一年該公司的每股收益幾乎沒有增長。儘管令人欣慰的是，三年前的每股收益總體上提升了 31%，但過去 12 個月的表現卻不盡如人意。因此，股東們可能會歡迎這些中期的盈利增長率。</p>
<p>展望未來，十位分析師預計未來三年每年將實現 17% 的增長。這一增長率顯著高於更廣泛市場的 12% 的年增長預測。</p>
<p>考慮到這一點，ESAB 的市盈率高於大多數其他公司的情況是可以理解的。顯然，股東們不願意拋售可能面臨更繁榮未來的股票。</p>
<h2>最終結論</h2>
<p>僅僅依靠市盈率來判斷是否應該出售你的股票並不明智，但它可以作為公司未來前景的實用指南。</p>
<p>我們已經確定，ESAB 維持其高市盈率是基於其預測增長高於更廣泛市場的預期。在這一階段，投資者認為盈利惡化的潛力不足以證明市盈率的降低。除非這些條件發生變化，否則他們將繼續為股價提供強有力的支持。</p>
<p>你始終需要注意風險，例如——<strong>ESAB 有 1 個警告信號</strong> 我們認為你應該注意。</p>
<p><strong>如果你對市盈率感興趣</strong>，你可能希望查看這份 <strong>免費</strong> 的其他強勁盈利增長和低市盈率公司的集合。</p>

ESAB

<p>ESAB 公司（紐約證券交易所代碼：ESAB）的市盈率為 26.4 倍，相較於許多美國公司而言偏高。儘管近期的盈利增長低於平均水平，分析師預測未來三年年均增長率為 17%，高於市場的 12%。這種樂觀情緒支撐了較高的市盈率，表明投資者對未來的改善持信心。然而，存在潛在風險，包括公司所提到的一個警示信號。在僅僅基於市盈率做出決策之前，投資者應考慮這些因素</p>

<p>With a price-to-earnings (or &#34;P/E&#34;) ratio of 26.4x <strong>ESAB Corporation</strong> (NYSE:ESAB) may be sending bearish signals at the moment, given that almost half of all companies in the United States have P/E ratios under 19x and even P/E's lower than 11x are not unusual. However, the P/E might be high for a reason and it requires further investigation to determine if it's justified.</p>
<div class="lb-trans"><p>以 26.4 倍的市盈率（&#34;P/E&#34;）來看，<strong>ESAB Corporation</strong>（紐約證券交易所代碼：ESAB）目前可能發出看跌信號，因為美國幾乎一半的公司市盈率低於 19 倍，甚至低於 11 倍的市盈率也並不罕見。然而，市盈率可能因某種原因而偏高，需要進一步調查以確定其合理性。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即將改變醫療保健。這 20 只股票正在從早期診斷到藥物發現等各個方面進行工作。最棒的是——它們的市值都在 100 億美元以下——現在仍然有機會提前佈局。</p>
</div><p>ESAB could be doing better as it's been growing earnings less than most other companies lately. One possibility is that the P/E is high because investors think this lacklustre earnings performance will improve markedly. If not, then existing shareholders may be very nervous about the viability of the share price.</p>
<div class="lb-trans"><p>ESAB 的表現可能更好，因為它的盈利增長低於大多數其他公司。一個可能性是，市盈率偏高是因為投資者認為這種乏力的盈利表現將顯著改善。如果沒有，那麼現有股東可能會對股價的可行性感到非常緊張。</p>
</div><p>View our latest analysis for ESAB</p>
<div class="lb-trans"><p>查看我們對 ESAB 的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/708077828-pe-multiple-vs-industry-1-dark-2/1767958651444" alt="" original-src="https://images.simplywall.st/asset/chart/708077828-pe-multiple-vs-industry-1-dark-2/1767958651444"/></p>
<p>NYSE:ESAB Price to Earnings Ratio vs Industry January 9th 2026</p>
<div class="lb-trans"><p>2026 年 1 月 9 日 NYSE:ESAB 市盈率與行業對比</p>
</div><p>If you'd like to see what analysts are forecasting going forward, you should check out our <strong>free</strong> report on ESAB.</p>
<div class="lb-trans"><p>如果你想了解分析師對未來的預測，可以查看我們關於 ESAB 的 <strong>免費</strong> 報告。</p>
</div><h2>Does Growth Match The High P/E?</h2>
<div class="lb-trans"><h2>增長是否匹配高市盈率？</h2>
</div><p>ESAB's P/E ratio would be typical for a company that's expected to deliver solid growth, and importantly, perform better than the market.</p>
<div class="lb-trans"><p>ESAB 的市盈率對於一家預計將實現穩健增長的公司來説是典型的，重要的是，它的表現應該優於市場。</p>
</div><p>Taking a look back first, we see that there was hardly any earnings per share growth to speak of for the company over the past year. Although pleasingly EPS has lifted 31% in aggregate from three years ago, notwithstanding the last 12 months. Accordingly, shareholders would have probably welcomed those medium-term rates of earnings growth.</p>
<div class="lb-trans"><p>首先回顧一下，我們看到過去一年該公司的每股收益幾乎沒有增長。儘管令人欣慰的是，三年前的每股收益總體上提升了 31%，但過去 12 個月的表現卻不盡如人意。因此，股東們可能會歡迎這些中期的盈利增長率。</p>
</div><p>Turning to the outlook, the next three years should generate growth of 17% per year as estimated by the ten analysts watching the company. That's shaping up to be materially higher than the 12% per annum growth forecast for the broader market.</p>
<div class="lb-trans"><p>展望未來，十位分析師預計未來三年每年將實現 17% 的增長。這一增長率顯著高於更廣泛市場的 12% 的年增長預測。</p>
</div><p>In light of this, it's understandable that ESAB's P/E sits above the majority of other companies. Apparently shareholders aren't keen to offload something that is potentially eyeing a more prosperous future.</p>
<div class="lb-trans"><p>考慮到這一點，ESAB 的市盈率高於大多數其他公司的情況是可以理解的。顯然，股東們不願意拋售可能面臨更繁榮未來的股票。</p>
</div><h2>The Final Word</h2>
<div class="lb-trans"><h2>最終結論</h2>
</div><p>Using the price-to-earnings ratio alone to determine if you should sell your stock isn't sensible, however it can be a practical guide to the company's future prospects.</p>
<div class="lb-trans"><p>僅僅依靠市盈率來判斷是否應該出售你的股票並不明智，但它可以作為公司未來前景的實用指南。</p>
</div><p>We've established that ESAB maintains its high P/E on the strength of its forecast growth being higher than the wider market, as expected. At this stage investors feel the potential for a deterioration in earnings isn't great enough to justify a lower P/E ratio. Unless these conditions change, they will continue to provide strong support to the share price.</p>
<div class="lb-trans"><p>我們已經確定，ESAB 維持其高市盈率是基於其預測增長高於更廣泛市場的預期。在這一階段，投資者認為盈利惡化的潛力不足以證明市盈率的降低。除非這些條件發生變化，否則他們將繼續為股價提供強有力的支持。</p>
</div><p>You always need to take note of risks, for example - <strong>ESAB has 1 warning sign</strong> we think you should be aware of.</p>
<div class="lb-trans"><p>你始終需要注意風險，例如——<strong>ESAB 有 1 個警告信號</strong> 我們認為你應該注意。</p>
</div><p><strong>If P/E ratios interest you</strong>, you may wish to see this <strong>free</strong> collection of other companies with strong earnings growth and low P/E ratios.</p>
<div class="lb-trans"><p><strong>如果你對市盈率感興趣</strong>，你可能希望查看這份 <strong>免費</strong> 的其他強勁盈利增長和低市盈率公司的集合。</p>
</div>

ESAB 公司（NYSE:ESAB）在投資者中受歡迎的程度顯而易見